抗精神病药物暴露与危重症患者无紧张症存活天数减少相关
该前瞻性队列研究在单中心学术医疗中心的医疗、外科和创伤ICU开展,纳入270例接受机械通气或血管升压药且无重大神经认知障碍、严重精神障碍或基线紧张症的危重症成人。主要暴露为入组后前5天和前14天抗精神病药物给药及累积剂量,主要结局为无紧张症存活天数(CFDs)。102例暴露于抗精神病药物的患者中27例(26%)发生紧张症;与从未暴露者相比,5天和14天模型暴露者获得更多CFD的比值分别降低74%和51%(OR 0.2568,95%CI 0.1580-0.4173;OR 0.4939,95%CI 0.3857-0.6325)。较高剂量暴露者与较低剂量暴露者相比,5天和14天模型获得更多CFD的比值分别降低97%(OR 0.0281,95%CI 0.0142-0.0556)和(OR 0.0335,95%CI 0.0166-0.0673)。作者认为该研究可能影响重症医生对抗精神病药物的使用方式,并可能支持多巴胺阻断是紧张症潜在生物学机制的证据。
要点
- 在270例危重症成人中,102例暴露于抗精神病药物,其中27例(26%)发生紧张症。
- 与从未暴露者相比,5天模型暴露者获得更多无紧张症存活天数的比值降低74%(OR 0.2568,95%CI 0.1580-0.4173)。
- 与从未暴露者相比,14天模型暴露者获得更多无紧张症存活天数的比值降低51%(OR 0.4939,95%CI 0.3857-0.6325)。
- 较高剂量暴露者与较低剂量暴露者相比,5天模型获得更多CFD的比值降低97%(OR 0.0281,95%CI 0.0142-0.0556)。
- 较高剂量暴露者与较低剂量暴露者相比,14天模型获得更多CFD的比值降低97%(OR 0.0335,95%CI 0.0166-0.0673)。
适用人群与场景
- 单中心学术医疗中心医疗、外科和创伤ICU的危重症成人患者。
- 纳入接受机械通气或血管升压药的患者。
- 排除基线有重大神经认知障碍、严重精神障碍或紧张症的患者。
诊断标准与关键阈值
- 紧张症评估采用Bush-Francis紧张症评定量表,映射至《精神疾病诊断与统计手册》第五版标准。
- 主要结局为无紧张症存活天数(CFDs),定义为患者存活且无紧张症的天数。
研究设计与关键结果
- 研究设计为前瞻性队列(Delirium and Catatonia Prospective Cohort Investigation),单中心,纳入270例危重症成人,中位年龄54.5岁(四分位距36.7-67.2岁)。
- 主要暴露为入组后前5天和前14天抗精神病药物给药及累积剂量;102例暴露于抗精神病药物,其中27例(26%)发生紧张症。
- 与从未暴露于抗精神病药物者相比,5天模型暴露者获得更多CFD的比值降低74%(OR 0.2568,95%CI 0.1580-0.4173),14天模型降低51%(OR 0.4939,95%CI 0.3857-0.6325)。
- 与较低剂量暴露者相比,较高剂量暴露者5天模型获得更多CFD的比值降低97%(OR 0.0281,95%CI 0.0142-0.0556),14天模型降低97%(OR 0.0335,95%CI 0.0166-0.0673)。
- 采用校正比例优势逻辑回归估计结局事件的比值比(OR)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该研究可能影响重症医生对抗精神病药物的使用方式,并可能支持多巴胺阻断是紧张症潜在生物学机制的证据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Catatonia occurs in critical illness, however, underlying causal mechanisms are unknown. We aim to determine if exposure to antipsychotic medication is associated with less days alive and free from catatonia in critically ill adults.
DESIGN: The Delirium and Catatonia Prospective Cohort Investigation is a prospective cohort.
SETTING: Single academic medical center's medical, surgical, and trauma ICUs.
PATIENTS: Critically ill adult patients on mechanical ventilation or vasopressors without a major neurocognitive disorder, severe psychiatric disorder, or catatonia at baseline.
INTERVENTIONS: The primary exposure was antipsychotic administration and cumulative dosage during the first 5 and 14 days from enrollment.
MEASUREMENTS AND MAIN RESULTS: Catatonia was evaluated with the Bush-Francis Catatonia Rating Scale mapped to Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition criteria. The primary outcome was catatonia-free days (CFDs), defined as the number of days the patient was alive and free from catatonia. Adjusted proportional odds logistic regression was used to estimate the odds ratio (OR) of outcome events. Patients ( n = 270) were enrolled with a median (interquartile range) age of 54.5 years (36.7-67.2 yr). Of patients who were exposed to antipsychotic medication ( n = 102), 27 (26%) experienced catatonia. Compared with patients who were never exposed to antipsychotics, those exposed in both the 5- and 14-day models had a 74% and 51% reduction in the odds of more CFD (OR, 0.2568; 95% CI, 0.1580-0.4173) and (OR, 0.4939; 95% CI, 0.3857-0.6325), respectively. Furthermore, those exposed to higher dosages had a 97% reduction in the odds of more CFD (OR, 0.0281; 95% CI, 0.0142-0.0556) and (OR, 0.0335; 95% CI, 0.0166-0.0673) compared with those exposed to lower dosages in both the 5- and 14-day models, respectively.
CONCLUSIONS: This study may influence how intensivists approach the use of antipsychotic medications and may build upon existing evidence that dopamine blockade is an underlying biologic mechanism underlying catatonia.
参考来源
- Mina GN, McGonigle T, Liu J, et al. Exposure to Antipsychotic Medication Is Associated With Less Days Alive and Free From Catatonia in Critically Ill Patients. Crit Care Med. 2026. PMID: 41805231. doi:10.1097/CCM.0000000000007077
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。